Ownership history in Bayesian Capital Management, LP Β· 8 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in WESTLAKE CHEM CORP (WLK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Bayesian Capital Management, LP underperformed the S&P 500 by β53.8% annually on this WLK position. Timing score: 57% (4/7 decisions correct). Average cost basis: $80.96. Maximum drawdown during holding period: β22.0%.
β Significantly underperformed the S&P 500 by 53.8% ann.
7 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
4 of 7 add/trim decisions correct
Best entry: $57.62 (2017 Q1) Β· Worst: $96.60 (2022 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
4 adds Β· 4 trims. Bought during 1 of 3 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.15% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size